Cited by 44Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Azole Antifungal Resistance Today: Focus on Aspergillus

Bowyer, Paul, Moore, Caroline B., Rautemaa, Riina, Denning, David W., Richardson, Malcolm D.·2011·Current Infectious Disease Reports

Abstract

Oral triazole therapy is well established for the treatment of invasive aspergillosis (IPA), allergic aspergillosis (ABPA), and chronic pulmonary aspergillosis (CPA), and is often long-term. Resistance to triazole azole antifungal drugs in Aspergillus fumigatus is now a major clinical problem in a number of European locations, in China, Canada and the USA with particularly high frequencies from the north-west of the UK, and The Netherlands. A number of centers are reporting the continuing increasing frequency and evolution of resistance mechanisms in A. fumigatus, in both azole-naïve and patients treated with azoles. The increasing rate of resistance is of concern. A number of resistance mechanisms have been found. The biofilm modality of Aspergillus growth may have a number of therapeutic implications for aspergillosis, including antifungal resistance. Microbiological diagnosis of aspergillosis is limited by poor culture yield, leading to uncertainty about the frequency of triazole resistance. Direct resistance testing in culture-negative clinical samples may add additional insights into the prevalence of azole resistance in A. fumigatus.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11908-011-0218-4

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Members from Acremonium, Aspergillus, Cladosporium, Fusarium, and Pneumocystis, in addition to Candida, are among the biofilm formers tested for drug susceptibility in vitro.

    “These include (in addition to Candida) members from Acremonium, Aspergillus, Cladosporium, Fusarium, and Pneumocystis (9, 20, 35, 42, 79, 160, 176).”

    From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [20]

  • Cells in biofilms have been found to be more resistant to drugs compared with cells grown in suspension culture.

    “For example, a number of these biofilm formers (Table 3) have been tested for drug susceptibility in vitro, and cells in biofilms have been found to be more resistant to drugs compared with cells grown in suspension culture.”

    From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [20]

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Bowyer, P., Moore, C. B., Rautemaa, R., Denning, D. W., & Richardson, M. D.
Affiliations
Manchester Academic Health Science Centre (GB)
Corresponding author
Richardson, Malcolm D.
Venue
Current Infectious Disease Reports
Published
2011-09-20
Volume
13
Issue
6
Pages
485-491
ISSN
  • 1523-3847 (ISSN-L)
  • 1534-3146
OpenAlex
W2070897511
Cited by
44
References
32
Citations by year
2024: 2 · 2022: 2 · 2020: 6 · 2019: 3 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 5
FWCI
3.45
Type
journal article
Language
en
Open access
closed
Locations
  • Current Infectious Disease Reports (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
azole resistance, triazole resistance, Aspergillus fumigatus, invasive aspergillosis, allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, antifungal resistance mechanisms, biofilm formation, resistance testing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review